<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study investigated the roles of <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> (<z:chebi fb="0" ids="15627">TXA2</z:chebi>), <z:chebi fb="13" ids="16761">ADP</z:chebi> and thrombin in middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) <z:mp ids='MP_0005048'>thrombosis</z:mp> in the rat </plain></SENT>
<SENT sid="1" pm="."><plain>The rat <z:chebi fb="70" ids="34342">MCA</z:chebi> was occluded by a <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> induced by the photochemical reaction of <z:chebi fb="0" ids="52261">rose bengal</z:chebi> by green light that causes endothelial damage followed by platelet <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, aggregation and formation of a platelet and fibrin-rich <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> at the site of the photochemical reaction </plain></SENT>
<SENT sid="2" pm="."><plain>Vapiprost, a specific <z:chebi fb="0" ids="15627">TXA2</z:chebi>-receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>; <z:chebi fb="0" ids="37941">clopidogrel</z:chebi>, which has the <z:chebi fb="0" ids="37942">thienopyridine</z:chebi> structure of <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> and is a more potent inhibitor of <z:chebi fb="13" ids="16761">ADP</z:chebi>-induced platelet aggregation than <z:chebi fb="0" ids="9588">ticlopidine</z:chebi>; argatroban, a specific thrombin inhibitor; or <z:chebi fb="5" ids="28304">heparin</z:chebi> was administered intravenously before <z:chebi fb="0" ids="52261">rose bengal</z:chebi> injection </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="70" ids="34342">MCA</z:chebi> local blood flow was monitored by a laser Doppler flowmeter </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="70" ids="34342">MCA</z:chebi> was occluded by <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> about 5 min after the initiation of the photochemical reaction </plain></SENT>
<SENT sid="5" pm="."><plain>Vapiprost, <z:chebi fb="0" ids="37941">clopidogrel</z:chebi> and argatroban <z:hpo ids='HP_0000001'>all</z:hpo> significantly prolonged the time taken for the thrombotic occlusion of the <z:chebi fb="70" ids="34342">MCA</z:chebi>, but in this respect, <z:chebi fb="5" ids="28304">heparin</z:chebi> was ineffective </plain></SENT>
<SENT sid="6" pm="."><plain>Our observations suggest that vapiprost and <z:chebi fb="0" ids="37941">clopidogrel</z:chebi> are useful antithrombotic agents against platelet and fibrin-rich <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The effect of argatroban is attributable to inhibition of thrombin-induced platelet activation and fibrin generation </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:mp ids='MP_0005048'>thrombosis</z:mp> model described in this study is useful for understanding the mechanism(s) of thrombogenesis in the rat <z:chebi fb="70" ids="34342">MCA</z:chebi> and may be applied to other mammalian species </plain></SENT>
</text></document>